T-cell Immunology: The maths of memory

Mathematical modeling reveals that long-term immunological memory is maintained in a manner that is even more dynamic than previously thought.
  1. Jose Borghans  Is a corresponding author
  2. Ruy M Ribeiro
  1. University Medical Center Utrecht, The Netherlands
  2. Universidade de Lisboa, Portugal

Immunological memory – the ability of the body to ‘remember’ and fight previously encountered pathogens – forms the basis of vaccination, which is one of the most important discoveries in the history of medicine. However, despite the enormous success of vaccination, we still do not fully understand how the body maintains long-term immunological memory, and this gap in our knowledge is hindering attempts to develop ‘next-generation vaccines’ and efforts to deploy immune cells called T cells against cancer.

The immune system contains many different types of cells. Some of these cells can recognize pathogens without ever having encountered them. However, other immune cells – including T cells – ‘learn on the job’: on first encountering a pathogen, these cells respond relatively slowly, but later form a 'memory' to respond more efficiently. To better understand how long-term immunological memory is maintained, we need to learn more about the dynamics of memory T cells. In particular, it will be necessary to understand the relative contribution of the following processes: the recruitment of new T cells (which are known as naive T cells) into the pool of memory T cells; the renewal of memory T cells by cell division; and the survival of individual memory T cells. However, quantifying these processes is challenging.

Previous research using cancer patient data indicated that memory T cells have a relatively short lifespan (Michie et al., 1992). Then, almost 20 years ago, DNA-labeling techniques led to a breakthrough in the study of T-cell dynamics by allowing researchers to track how rapidly T cells divide and die (Hellerstein et al., 1999). These methods were later used to confirm that memory T cells live for six months or less in healthy humans (Westera et al., 2013), whereas naive T cells can live for up to nine years (Vrisekoop et al., 2008). Thus, a long life is not a key characteristic of memory T cells. Instead, immunological memory, which can last for a lifetime (Crotty and Ahmed, 2004), is maintained by relatively short-lived cells. However, it remains unclear to what extent the pool of memory T cells is maintained by the division of existing memory T cells or through the recruitment of naive T cells to the pool. The latter process is thought to play only a minor role because naive T cells are highly variable, and the chance of a given naive T cell entering the pool of memory T cells is thus extremely low.

Now, in eLife, immunologists from the University of Glasgow, the Icahn School of Medicine at Mount Sinai and the Royal Free Hospital – Graeme Gossel, Thea Hogan, Daniel Cownden, Benedict Seddon and Andrew Yates – report how they have used two independent approaches to study how T-cell memory is maintained (Gossel et al., 2017). In a technique called ‘temporal fate mapping’, Gossel et al. used the cancer drug busulfan to kill hematopoietic stem cells (that is, stem cells that go on to become blood cells like T cells) in the bone marrow of mice, while leaving their peripheral T-cell pools intact. They then transplanted bone marrow cells from donor mice, which mature into T cells that differ only in one protein marker (CD45) expressed on their surface. Thus, in these mice, the researchers were able to distinguish newly formed T cells from the original T cells, and to track which cells were being replaced and measure their dynamics (Figure 1A).

The dynamics of memory T cells.

Gossel et al. used two experimental approaches to study the dynamics of memory T cells in mice. (A) To quantify the influx of naive T cells into the pool of existing memory T cells, they used the drug busulfan to selectively kill hematopoietic stem cells (HSC) in the bone marrow of CD45.1+ mice (red arrow), and then added new cells derived from bone marrow of CD45.2+ mice (green arrow). Naive T cells (light blue bubble) replaced around 10% of central memory T cells (CM) and about 6% of effector memory T cells (EM) per week (blue arrows). About half of the resident memory T-cell population was never replaced. (B) In a second experiment, the DNA of memory T cells was labeled with the marker BrdU to measure how rapidly cells in different memory T-cell subpopulations divide and die. By measuring the marker Ki67 (purple arrow), they could classify CM and EM cells into recently divided (Ki67+) and not recently divided (Ki67-) cells. Both the CM and the EM pools contained cells with fast and slow dynamics: the short-lived cells lived around three days and six days, respectively, while the long-lived cells lived for around six weeks in both subpopulations. (C) In the future, it might be useful to combine these two approaches to compare the cell division and death of recently recruited (CD45.2+) and pre-existing memory T cells (CD45.1+).

© 2007, Seans Potato Business, Wikimedia Commons, Creative Commons Attribution-Share Alike 3.0 Unported. Mouse used in Figure 1 parts A-C is reproduced with permission from Seans Potato Business.

Even though the mice did not have any infections to activate naive T cells, there appeared to be a constant large influx of naive T cells into the pool of memory T cells. The memory T-cell pool has different subpopulations, including central memory T cells and effector memory T cells, which can be distinguished by the different protein markers found on their surface. Gossel et al. discovered that naive T cells replaced around 10% of the central memory T cells every week. For effector memory T cells this figure was around 6% per week in young adults and 1% per week in older mice. Importantly, they showed that by neglecting this large flux from the naive T-cell pool into the memory pool, previous studies may have significantly overestimated the lifespan of memory T cells.

Despite this rapid replacement of memory T cells by new naive T cells, around 50% of the pool of memory T cells that had formed before the mice were eight weeks old was never replaced by new naive T cells. Thus, although a substantial fraction of the memory T-cell pool is replaced at high rates throughout life, an equally large proportion is kept from an early age. The question still remains whether these ‘original’ T cells simply have a long lifespan or are maintained through cell division.

To better understand the dynamics of the different T-cell sub-populations, Gossel et al. labeled the DNA of cells undergoing cell division and measured the protein Ki67, which cells naturally express during division (Figure 1B). The Ki67 marker was then used as a ‘time stamp’ that tagged cells that had recently divided, while DNA-labeling was used to trace the dynamics of both ‘stamped’ and ‘non-stamped’ cells. Gossel et al. show for the first time that both the central memory and the effector memory T-cell pool are composed of T-cell subsets with intrinsically different dynamics. In both pools around half of the cells live for just a few days while the other half, on average, live for around six weeks.

This study beautifully combines detailed quantitative experiments with mathematical models, and thereby reveals important insights into the long-term maintenance of memory T cells. However, the work also raises many questions. For example, it has recently been shown that the pool of memory T cells of laboratory mice resembles that of human babies more than that of human adults (Beura et al., 2016). If new naive T cells replace up to 10% of the memory T-cell pool per week even in clean laboratory environments, one may wonder how much they would replace in humans, who are continuously exposed to pathogens.

It is also still not clear what is driving these cells into the memory T-cell pool and if chronic latent infections continuously recruit new naive T cells into the memory pool. Nevertheless, a substantial fraction of the memory T-cell pool appears to be resistant and cannot be replaced by new cells from the naive T-cell pool. Future research should address what makes these T cells resistant and whether they cannot be replaced even during infections. Last but not least, one may wonder, what is the benefit of combining a pool of memory T cells that is never replaced with one that is quickly and continuously replaced?

References

Article and author information

Author details

  1. Jose Borghans

    Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
    For correspondence
    J.Borghans@umcutrecht.nl
    Competing interests
    The authors declare that no competing interests exist.
  2. Ruy M Ribeiro

    Laboratório de Biomatemática, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
    Competing interests
    The authors declare that no competing interests exist.

Publication history

  1. Version of Record published: April 28, 2017 (version 1)

Copyright

© 2017, Borghans et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 29,970
    views
  • 873
    downloads
  • 11
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jose Borghans
  2. Ruy M Ribeiro
(2017)
T-cell Immunology: The maths of memory
eLife 6:e26754.
https://doi.org/10.7554/eLife.26754

Further reading

    1. Cell Biology
    2. Computational and Systems Biology
    Trine Line Hauge Okholm, Andreas Bjerregaard Kamstrup ... Christian Kroun Damgaard
    Research Article

    Circular RNAs represent a class of endogenous RNAs that regulate gene expression and influence cell biological decisions with implications for the pathogenesis of several diseases. Here, we disclose a novel gene-regulatory role of circHIPK3 by combining analyses of large genomics datasets and mechanistic cell biological follow-up experiments. Using time-course depletion of circHIPK3 and specific candidate RNA-binding proteins, we identify several perturbed genes by RNA sequencing analyses. Expression-coupled motif analyses identify an 11-mer motif within circHIPK3, which also becomes enriched in genes that are downregulated upon circHIPK3 depletion. By mining eCLIP datasets and combined with RNA immunoprecipitation assays, we demonstrate that the 11-mer motif constitutes a strong binding site for IGF2BP2 in bladder cancer cell lines. Our results suggest that circHIPK3 can sequester IGF2BP2 as a competing endogenous RNA (ceRNA), leading to target mRNA stabilization. As an example of a circHIPK3-regulated gene, we focus on the STAT3 mRNA as a specific substrate of IGF2BP2 and validate that manipulation of circHIPK3 regulates IGF2BP2-STAT3 mRNA binding and, thereby, STAT3 mRNA levels. Surprisingly, absolute copy number quantifications demonstrate that IGF2BP2 outnumbers circHIPK3 by orders of magnitude, which is inconsistent with a simple 1:1 ceRNA hypothesis. Instead, we show that circHIPK3 can nucleate multiple copies of IGF2BP2, potentially via phase separation, to produce IGF2BP2 condensates. Our results support a model where a few cellular circHIPK3 molecules can induce IGF2BP2 condensation, thereby regulating key factors for cell proliferation.

    1. Cell Biology
    2. Computational and Systems Biology
    N Suhas Jagannathan, Javier Yu Peng Koh ... Lisa Tucker-Kellogg
    Research Article

    Bats have unique characteristics compared to other mammals, including increased longevity and higher resistance to cancer and infectious disease. While previous studies have analyzed the metabolic requirements for flight, it is still unclear how bat metabolism supports these unique features, and no study has integrated metabolomics, transcriptomics, and proteomics to characterize bat metabolism. In this work, we performed a multi-omics data analysis using a computational model of metabolic fluxes to identify fundamental differences in central metabolism between primary lung fibroblast cell lines from the black flying fox fruit bat (Pteropus alecto) and human. Bat cells showed higher expression levels of Complex I components of electron transport chain (ETC), but, remarkably, a lower rate of oxygen consumption. Computational modeling interpreted these results as indicating that Complex II activity may be low or reversed, similar to an ischemic state. An ischemic-like state of bats was also supported by decreased levels of central metabolites and increased ratios of succinate to fumarate in bat cells. Ischemic states tend to produce reactive oxygen species (ROS), which would be incompatible with the longevity of bats. However, bat cells had higher antioxidant reservoirs (higher total glutathione and higher ratio of NADPH to NADP) despite higher mitochondrial ROS levels. In addition, bat cells were more resistant to glucose deprivation and had increased resistance to ferroptosis, one of the characteristics of which is oxidative stress. Thus, our studies revealed distinct differences in the ETC regulation and metabolic stress responses between human and bat cells.